A study for the evaluation of safety and tolerability of intravenous high-dose iron sucrose in patients with iron deficiency anemia due to gastrointestinal bleeding

Zeitschrift fur Gastroenterologie

Volumn 42, Issue 8, 2004, Pages 663-667

  Schroder O ^a   Schrott, M ^a   Blumenstein, I ^a   Jahnel, J ^b   Dignass, A U ^b   Stein, Jürgen ^a,c  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c Department of Medicine   (Germany)

Author keywords

Anemia; Gastrointestinal blood loss; Inflammatory bowel disease; Intravenous iron infusion; Iron sucrose

Indexed keywords

FERRIC HYDROXIDE SUCROSE;

ABDOMINAL PAIN; ADULT; AGED; ANAPHYLAXIS; ARTICLE; CLINICAL ARTICLE; DRUG SAFETY; DRUG TOLERABILITY; EDEMA; ERYTHROPOIESIS; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEADACHE; HUMAN; IRON DEFICIENCY ANEMIA; IRON THERAPY; MALE; MYALGIA; NAUSEA; OUTPATIENT; PATIENT COMPLIANCE; PHLEBITIS; URTICARIA;

ADULT; AGED; AGED, 80 AND OVER; ANAPHYLAXIS; ANEMIA, IRON-DEFICIENCY; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG TOLERANCE; EDEMA; FEMALE; FERRIC COMPOUNDS; GASTROINTESTINAL HEMORRHAGE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; NAUSEA; THROMBOPHLEBITIS; TREATMENT OUTCOME; URTICARIA;

EID: 4444247093     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-813106     Document Type: Article

References (16)

1. World health report 2002 - reducing risks, promoting healthy life. Geneva: World Health Organization, 2002.
2. Rockey DC, Cello JP. Evaluation of the gastrointestinal tract in patients with iron deficient anemia. N Engl J Med 1993; 329: 1691-1695
3. Kepczyk T, Kadakia SC. Prospective evaluation of gastrointestinal tract in patients with iron-deficient anemia. Dig Dis Sci 1995; 40: 1283-1289
4. Truelove SC, Wilts LJ. Cortisone in ulcerative colitis. Final report on a therapeutic trial. Br Med J 1955; 2: 1041-1048
5. Beal RW, Skyring AP, McRae J et al. The anemia of ulcerative colitis. Gastroenterology 1963; 45: 589-603
6. Both H, Torp-Pedersen K, Kreiner S et al. Clinical appearance at diagnosis of ulcerative colitis and Crohn's disease in a regional patient group. Scand J Gastroenterology 1983; 18: 987-991
7. Anatkov A, Gekova K. The use of large intravenous doses of iron in the treatment of iron-deficiency anaemia. Haematology and Transfusiology 1970; 13: 295-298
8. Al-Hawas F, Abdalla AH, Popovich W et al. Use of i. v. iron saccharate in haemodialysis patients non responding to oral iron and erythropoietin. Nephrol Dial Transplant 1997; 12: 2801-2802
9. Ahmed K, Sadiq I, Yousuf AW. Injectable iron therapy: intramuscular vs intravenous therapy. Biomedica 2000; 16: 44-47
10. Domrongkitchaiporn S, Jirakkanont B, Atamasrikul K et al. Indices of iron status in continuous ambulantory peritoneal dialysis patients. Am J Kidney Dis 1999; 34: 29-35
11. Chandler G, Harchowal J, Macdougall IC. Intravenous iron sucrose: establishing a safe dose. Am J Kidney Dis 2001; 38: 988-991
12. Blaustein DA, Schwenk MH, Chattopadhyay J et al. The safety and efficacy of an accelerated iron sucrose dosing regimen in patients with chronic kidney disease. Kidney Int 2003; 64: 72-77
13. Gasché C. Anemia in IBD. The overlooked villain. Inflamm Bowel Dis 2000; 6: 142-150
14. Gasché C, Dejaco C, Waldhoer D. Intravenous iron and erythropoietin for anemia associated with Crohn disease. Ann Intern Med 1997; 126: 782-787
15. Gasché C, Dejaco C, Reinisch W et al. Sequential treatment of anemia in ulcerative colitis with intravenous iron and erythropoietin. Digestion 1999; 60: 262-267
16. Yee J, Besarab A. Iron sucrose: the oldest iron therapy becomes new. Am J Kidney Dis 2002; 40: 1111-1121